newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Participation in the ASGCT 25th Annual Meeting Including Oral Presentation About Beta-thalassemia Program

Accepted abstracts highlight next-generation gene editing programs GPH101 for sickle cell disease and GPH102 for beta-thalassemia Chief Scientific Officer Dr. Jane Grogan to participate in scientific symposium Graphite Bio, Inc. (NASDAQ:GRPH), a c